Clinical Trials on Platysma Prominence

Total 3848 results

Allergan

Completed

A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence

Platysma Prominence

United States, Belgium, Canada, Germany, United Kingdom
Allergan

Completed

A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence

Platysma Prominence

United States, Canada
Allergan

Completed

A Study To Assess the Safety of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence

Platysma Prominence

United States, Canada
Merz Aesthetics GmbH

Completed

A Study of NT 201 Doses in the Treatment of Platysma Prominence (PAOLA)

Platysma Prominence

United States
Allergan

Completed

BOTOX® for the Treatment of Platysma Prominence

Platysma Prominence

United States, Canada
AbbVie

Recruiting

A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult Participants

Masseter Muscle Prominence

Japan
AbbVie

Recruiting

A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants

Masseter Muscle Prominence

United States
AbbVie

Recruiting

A Study to Assess the Effectiveness of BOTOX (Botulinum Toxin Type A) Injections for the Change of Masseter Muscle Prominence in Adult Participants

Masseter Muscle Prominence

Bulgaria, Germany, Spain, Italy, United Kingdom, Belgium, France
AbbVie

Recruiting

A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence

Masseter Muscle Prominence

United States
Allergan

Completed

BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence

Masseter Muscle Prominence

United States
Allergan

Completed

BOTOX® Treatment for Adults With a Wide Lower Face Due to Masseter Muscle Prominence

Masseter Muscle Prominence

Canada, China, Taiwan
Allergan

Completed

Long Term Prospective Uncontrolled Study Of Earfold™ For The Treatment Of Prominent Ears (FOLD)

Prominent Ears

United Kingdom
University of Campinas, Brazil

Completed

Analysis of Postoperative Bandage Use Protocols in Otoplasty

Prominent Ears

Brazil
Physicians Research And Education Network

Terminated

The Quietude Study: Quetiapine Use for Agitated Depression

Depression With Prominent Agitation

Canada
Clinical Testing of Beverly Hills
Galderma R&D

Active, not recruiting

Dysport Dose-Ranging Treatment of Platysmal Bands

Platysma Bands

United States
Galderma R&D

Completed

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands

Platysmal Bands

United States
University of Texas Southwestern Medical Center
Becton, Dickinson and Company

Completed

A Randomized Trial Examining Plasma Exchange Using the Becton Dickinson (BD) Catheter In an Outpatient Apheresis Unit (REPLACE)

Plasma Exchange

United States
Benedictine University

Unknown

Effects of Exercise and 5-HTP on Cortisol Levels

Plasma Cortisol

United States
Boston University

Completed

Evaluation of a Device That Separates Blood Cells From Serum/Plasma

Plasma Extraction

United States
AcelRx Pharmaceuticals, Inc.

Completed

Single and Multiple Dose Pharmacokinetics of Sufentanil NanoTab

Plasma Concentrations

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Plasma Cell Leukemia

United States
AstraZeneca

Completed

Study to Investigate the Safety Profile of AZD4721 After Single Doses at Different Dose Levels

Safety,Plasma AUC and Cmax, Plasma AUC 0-t, t1/2λz, and Tmax

United Kingdom
IRCCS Centro di Riferimento Oncologico della Basilicata
Celgene Corporation

Completed

Lenalidomide and Dexamethasone in Primary Plasma Cell Leukemia

Primary Plasma Cell Leukemia

Italy
Rennes University Hospital

Completed

TPE in Rennes Hospital (COMPLASMA)

Therapeutic Plasma Exchange

France
PepsiCo Global R&D

Completed

Comparison of Plasma Caffeine Concentration After Oral Consumption of Caffeinated Beverages With Varied Bioactive Compounds in Healthy Volunteers

Plasma Caffeine Concentration

United States
Nanyang Technological University

Completed

Nitrate and Power Output After Two Beetroot Juice Drinks

Blood Plasma Nitrite

Singapore
Cliniques universitaires Saint-Luc- Université...

Completed

IMPACT OF THERAPEUTIC PLASMA EXCHANGE ON ACQUIRED VACCINAL ANTI-SARS-CoV-2 ANTIBODIES.

Therapeutic Plasma Exchange

Belgium
Assiut University

Unknown

Effect of Platelet-Rich-Plasma in Spine Fusion

Platelet-Rich Plasma
B. Braun Melsungen AG

Completed

Safety Profile of Hydroxyethyl Starch

Plasma Volume Replacement

Malaysia, China
Mayo Clinic
National Cancer Institute (NCI)

Completed

Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
National Cancer Institute (NCI)

Completed

Vismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
Emory University
National Cancer Institute (NCI); Merck Sharp & Dohme LLC; National Institutes...

Completed

Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | ISS Stage III Plasma Cell Myeloma | ISS Stage II Plasma Cell Myeloma | ISS Stage I Plasma Cell Myeloma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma

Refractory Plasma Cell Myeloma | Plasmacytoma | Recurrent Plasma Cell Myeloma | Plasma Cell Leukemia

United States
Albert Einstein College of Medicine
National Cancer Institute (NCI)

Terminated

Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Refractory Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma | DS (Durie/Salmon) Stage I Plasma Cell Myeloma

United States
Albert Einstein College of Medicine
National Cancer Institute (NCI)

Completed

Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Withdrawn

Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma

Plasma Cell Myeloma | Plasma Cell Leukemia in Remission

United States
University of Southampton
Food Standards Agency, United Kingdom; Ocean Nutrition

Completed

Effect of Oily Fish Intake, Sex, Age, BMI, and APOE Genotype on Plasma Long Chain n-3 Fatty Acid Composition

Plasma Omega-3 Status

United Kingdom
Harrison, Theodore, M.D.

Unknown

Calculation of Platelet-rich Plasma Preparation Yield

Platelet-rich Plasma Production

Canada
FrieslandCampina
Wageningen University and Research

Completed

Dairy and Plant Amino Acid Uptake. An Explorative Study (DaPa)

Amino Acid Plasma Profile

Netherlands
Seoul National University Hospital

Completed

Effect of Tidal Volume Change on Pressure-based Prediction of Fluid Responsiveness in Children

Plasma Volume | Tidal Volume

Korea, Republic of
AstraZeneca

Completed

Explore the Performance of IntelliCap.

Pharmacokinetic Profile | Plasma Concentration

United Kingdom
Peterson, Noel, N.D.

Completed

Efficacy of Training in Manual Preparation of Platelet Rich Plasma

Platelet Rich Plasma Production

United States
Roswell Park Cancer Institute
Celgene

Active, not recruiting

SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy

Plasma Cell Myeloma | Partial Response of Multiple Myeloma or Plasma Cell Leukemia

United States
National Cancer Institute (NCI)

Completed

FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
National Cancer Institute (NCI)

Withdrawn

RO4929097 After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
Ramsay Générale de Santé
European Clinical Trial Experts Network

Completed

Constitutive Study of a Serum Bank and Plasma Bank of Healthy Subjects Comparators to Dialysis Subjects (SPSSCD) (SPSSCD)

Dialysis | Serum Bank | Plasma Bank

France
Astellas Pharma Inc

Completed

A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet and Conventional Tablet Under With Water Intake

Healthy | Plasma Concentration of YM060

Japan
Chang Gung Memorial Hospital

Completed

Systemic Effects After Local Injection of Platelet-rich Plasma

Platelet Rich Plasma (PRP)

Taiwan

Clinical Trials on Platysma Prominence

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations